CLL-118 A Phase 1 Study With the Novel B-Cell Lymphoma 2 Inhibitor BGB-11417 as Monotherapy or in Combination With Zanubrutinib in Patients With B-Cell Malignancies: Preliminary Data

Autor: Soumerai, Jacob D. 1, Opat, Stephen 2, 3, Cheah, Chan Y. 4, 5, 6, Lasica, Masa 7, Verner, Emma 8, 9, Browett, Peter J. 10, Chan, Henry 11, Barca, Eva González 12, Hilger, James 13, Fang, Yiqian 13, Simpson, David 13, Tam, Constantine S. 14, 15, 16
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia October 2022 22 Supplement 2:S267-S268
Databáze: ScienceDirect
Externí odkaz: